title: Integrating smoking cessation into HIV care.
authors.forename: Linda
authors.initials: L
authors.lastname: Drach
authors.forename: Tim
authors.initials: T
authors.lastname: Holbert
authors.forename: Julie
authors.initials: J
authors.lastname: Maher
authors.forename: Victor
authors.initials: V
authors.lastname: Fox
authors.forename: Stacey
authors.initials: S
authors.lastname: Schubert
authors.forename: Laura Chisholm
authors.initials: LC
authors.lastname: Saddler
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D006078:Government Programs / Q000191:economics / Q000379:methods; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D018722:Nicotinic Agonists / Q000627:therapeutic use; D009922:Oregon; D011810:Quinoxalines / Q000627:therapeutic use; D012907:Smoking / Q000628:therapy*; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention; D014029:Tobacco Use Disorder / Q000188:drug therapy*; D000068580:Varenicline
chemical_list: D019380:Anti-HIV Agents; D001552:Benzazepines; D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D011810:Quinoxalines; D016642:Bupropion; D000068580:Varenicline